Cardinal Health (CAH) vs EnerSyn Global (ESYN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Cardinal Health (CAH) has outperformed EnerSyn Global (ESYN) over the past year, gaining 30.2% versus a loss of 26.5%. Cardinal Health is the larger company by market cap ($63.06 billion vs $37.4 million), about 1684.4 times the size. Cardinal Health pays a dividend yielding 0.75%, while EnerSyn Global does not currently pay one.
Cardinal Health converts more of its revenue into profit, with a net margin of 0.7% versus -303.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CAH | ESYN |
|---|---|---|
| Share price | $272.81 | $1.11 |
| Market cap | $63.06B | $37.44M |
| 1-day change | +0.17% | -0.89% |
| YTD return | +32.75% | -25.50% |
| 1-year return | +30.23% | -26.49% |
| 5-year return | +473.13% | — |
| P/E ratio (TTM) | 35.29 | — |
| Forward P/E | 18.89 | — |
| EPS (TTM) | $7.73 | $-0.58 |
| Dividend yield | 0.75% | 0.00% |
| Annual dividend | $2.05 | $0.00 |
| Revenue (latest FY) | $254.25B | $866.93K |
| Revenue growth (YoY) | +14.23% | -30.84% |
| Net income (latest FY) | $1.71B | $-2.63M |
| Gross margin | 3.84% | 53.03% |
| Operating margin | 1.03% | — |
| Net margin | 0.67% | -303.44% |
| 52-week high | $286.29 | $2.81 |
| 52-week low | $180.45 | $0.88 |
| Distance from 52-week high | -4.71% | -60.50% |
| Analyst consensus | buy | — |
| Avg. price target upside | +8.09% | — |
| Average volume | 1.72M | 38.17K |
| Shares outstanding | 231.14M | 33.73M |
| Employees | 58,788 | 4 |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cardinal Health is about 1684.4 times larger than EnerSyn Global by market value ($63.06B vs $37.44M).
- CAH has outperformed ESYN by 56.7 percentage points over the past year.
- Cardinal Health is more profitable, keeping 0.7 cents of every revenue dollar as net income versus -303.4 cents for EnerSyn Global.
- Cardinal Health grew revenue faster in its latest fiscal year (+14.23% vs -30.84%).
About Cardinal Health
CAH stock →Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally.
Health Care · Other Pharmaceuticals · 58,788 employees
About EnerSyn Global
ESYN stock →EnerSyn Global Inc. engages in the food and beverage business in Singapore and South Korea.
Health Care · Other Pharmaceuticals · 4 employees
CAH vs ESYN FAQ
Which is bigger, Cardinal Health or EnerSyn Global?
Cardinal Health (CAH) is larger, with a market capitalization of $63.06B compared with $37.44M for EnerSyn Global (ESYN).
Which stock has performed better over the past year, CAH or ESYN?
CAH returned +30.23% over the past 12 months, compared with -26.49% for ESYN (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Cardinal Health or EnerSyn Global?
Cardinal Health pays a dividend yielding 0.75%, while EnerSyn Global does not currently pay a regular dividend.
Are Cardinal Health and EnerSyn Global in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.